When care raises a concern

The exact product matters

Which cautions apply to this medicine and to your health history? Ask the person treating you about other medicines, allergies, and pregnancy plans.

Compounding means making medicine to order. FDA stands for Food and Drug Administration. This agency reviews medicines in the U.S.

FDA reports checked September 26, 2026, describe problems from poor compounding.

Active ingredient means the substance in the medicine that produces its effect.

A poorly made medicine may contain germs or the wrong amount of active ingredient, whether too much or too little.

Ask about labels before there is confusion

FDA reports checked September 26, 2026, describe patients measuring the wrong amount of made-to-order semaglutide for injection. Some people providing care also calculated the amount wrongly.

Some cases needed hospital care.

The body naturally makes a signal called GLP-1 that affects blood sugar and hunger. Semaglutide and tirzepatide are medicines that copy this signal.

On September 8, 2026, Arizona’s Nursing Board shared a warning about made-to-order GLP-1 medicines. Different label wording and medicine amounts could cause confusion when measuring them.

The warning is about a kind of product, not a finding about your own bottle.

Ask the person prescribing or the pharmacist to explain the medicine amount and every unclear part of the label.

Storage is a product question

Storage needs differ among peptide medicines. Follow the instructions for that exact product from its label and the pharmacy.

In advice checked September 17, 2026, FDA said to avoid injected GLP-1 medicines delivered warm or with too little cooling.

Ask the pharmacy about a delivery concern and what happens next.

There is a route for reporting a problem

Patients can report medicine problems through MedWatch, the FDA’s reporting program.

Keep the product label and the details of what happened for that conversation.